Company: IPCX
Filing Date: 2025-04-16
Form Type: S-1/A
Source: 0001213900-25-032632
Chunk: 122

Company: Inflection Point Acquisition Corp. III
Filing Date: 2025-04-16
Form: S-1/A
Chunk 122
---
003 per share. As a result, the value of your public shares may be significantly diluted in the event we consummate an initial business combination. For example, the following table shows the public shareholders’ and our sponsor’s investment per share and how that compares to the implied value of one Class A ordinary share upon the consummation of our initial business combination if at that time we were valued at $210,100,000 (which is the amount we would have in the trust account for our initial business combination assuming the underwriters’ over -allotmentoption is not exercised and following payment of the underwriters’ deferred fee), no interest is earned on the funds held in the trust account, and no public 79

shares are redeemed in connection with our initial business combination. At such valuation, each of our ordinary shares would have an implied value of $7.00 per share, which is a 30.0% decrease as compared to the initial implied value per public share of $10.00.

| Public shares                                                                |     |   |  22,000,000 |
| Founder shares                                                               |     |   |   7,333,333 |
| Private Placement Shares                                                     |     |   |     740,000 |
| Total shares                                                                 |     |   |  30,073,333 |
| Total funds in trust available for initial business combination(1)           |     | $ | 210,100,000 |
| Public shareholders’ investment per Class A ordinary share(2)                |     | $ |       10.00 |
| Sponsor’s investment per share(3)                                            |     | $ |        0.69 |
| Implied value per share upon consummation of initial business combination(1) |     | $ |        6.99 |

__________ (1)Does not take into account other potential impacts on our valuation at the time of the business combination, such as the trading price of our public shares, the terms of the business combination transaction (including any equity issued to or retained by, or cash or other consideration paid to, the target’s shareholder or other third parties), the business combination transaction costs (except for the payment of $9,900,000 of deferred underwriting commissions), or the target’s business itself, including its assets, liabilities, management and prospects. For instance, the potential dilution experienced by holders of our ordinary shares may be mitigated if the business combination agreement is structured such that the potential dilutive impact of